←
Circ: PHO9,368 posts
Circ: PHO avatar

Circ: PHO

@CircOutcomes

Circulation: Population Health and Outcomes, an American Heart Association journal. RT/follows do not imply endorsement.

◷ Joined September 2013▧ 1,298 Photos and videos
Circ: PHO avatar
Circ: PHO@CircOutcomes·Jul 24

For years, Circulation: Population Health and Outcomes has published research that helps shape cardiovascular health across communities and health systems. We're excited to announce Dhruv S. Kazi, MD, MSc, MS, (@kardiologykazi) as the next Editor-In-Chief.

Post attachment
Circ: PHO avatar
Circ: PHO@CircOutcomes·Nov 10

ICYMI: Lp(a)FRONTIERS EXPANSION Study @kcferdmd et al 📍Presented at #ScientificSessions26 📝Simultaneous Publication in @CircOutcomes Read More: 🔗ahajournals.org/doi/10.1161/… @AHAScience

Sim pub #ScientificSessions26 1st dedicated RCT of Lp(a)-lowering therapy in US Black/African American &Hispanic adults w/ Lp(a) >125 & ASCVD Lp(a)FRONTIERS EXPANSION (n=422),monthly pelacarsen 80 mg led to an 86% placebo-adjusted Lp(a)reduction at week 52 & was well tolerated

Post attachment
Harpreet Bhatia avatar
⟳ Circ: PHO retweeted
Harpreet Bhatia@hsbhatia·Nov 10

This trial demonstrates the feasibility of recruiting and retaining individuals typically underrepresented in cardiovascular clinical trials - Black and Hispanic individuals, and women. This study raises the bar and shows us what we should expect in clinical trials.

Don't miss the accompanying Editorial by @hsbhatia: Lp(a)FRONTIERS EXPANSION: Raising the Bar for Cardiovascular Clinical Trials #ScientificSessions26 🔗ahajournals.org/doi/10.1161/… @AHAScience @kardiologykazi @iamritu @kcferdmd

Circ: PHO avatar
Circ: PHO@CircOutcomes·Nov 10

ICYMI: 📍Featured Science Presentation @ #ScientificSessions26 | Simultaneous Publication in @CircOutcomes The Lp(a)FRONTIERS EXPANSION Study @kcferdmd et al 🔗ahajournals.org/doi/10.1161/…

Sim pub #ScientificSessions26 1st dedicated RCT of Lp(a)-lowering therapy in US Black/African American &Hispanic adults w/ Lp(a) >125 & ASCVD Lp(a)FRONTIERS EXPANSION (n=422),monthly pelacarsen 80 mg led to an 86% placebo-adjusted Lp(a)reduction at week 52 & was well tolerated

Post attachment
Circ: PHO avatar
Circ: PHO@CircOutcomes·Nov 9

Don't miss the accompanying Editorial by @hsbhatia: Lp(a)FRONTIERS EXPANSION: Raising the Bar for Cardiovascular Clinical Trials #ScientificSessions26 🔗ahajournals.org/doi/10.1161/… @AHAScience @kardiologykazi @iamritu @kcferdmd

Sim pub #ScientificSessions26 1st dedicated RCT of Lp(a)-lowering therapy in US Black/African American &Hispanic adults w/ Lp(a) >125 & ASCVD Lp(a)FRONTIERS EXPANSION (n=422),monthly pelacarsen 80 mg led to an 86% placebo-adjusted Lp(a)reduction at week 52 & was well tolerated

Post attachment
Circ: PHO avatar
Circ: PHO@CircOutcomes·Nov 9

🔗ahajournals.org/doi/10.1161/… 📌Featured Science Simultaneous Publication #ScientificSessions26 📝Article by @kcferdmd @FaRodriguezMD @DrMichaelShapir et al @ducciobaldari @WFCardiology @TulaneMedicine @iamritu @AHAScience @kardiologykazi @bnallamo

Circ: PHO avatar
Circ: PHO@CircOutcomes·Nov 9

Sim pub #ScientificSessions26 1st dedicated RCT of Lp(a)-lowering therapy in US Black/African American &Hispanic adults w/ Lp(a) >125 & ASCVD Lp(a)FRONTIERS EXPANSION (n=422),monthly pelacarsen 80 mg led to an 86% placebo-adjusted Lp(a)reduction at week 52 & was well tolerated

Post attachment
Circ: PHO avatar
Circ: PHO@CircOutcomes·Nov 9

Concomitantly, major adverse event readmissions decreased (1.74 → 0.9/100 pts) (🧵3/3)

Circ: PHO avatar
Circ: PHO@CircOutcomes·Nov 9

New study from 77 centers of 5,495 infants w/ this condition showed enrollment in the NPC-QIC resulted improved interstage survival b/w stage 1&2 surgical palliations from 90.5% to 94.8% & remained at this level for nearly a decade (2016-2025) (🧵2/3)

Post attachment
Circ: PHO avatar
Circ: PHO@CircOutcomes·Nov 9

📌Sim Pub with #ScientificSessions26 Cross-sectional study representing 147.3 million U.S adults (NHANES, 2015-2020) finds that among those recommended for lipid-lowering Rx (LLT) by guidelines, 12.8% use supplements instead ~4.2 million folks. Read more ⬇️

Post attachment